DEV Community

Md Kawsar
Md Kawsar

Posted on

AI in science: every researcher now has an AI lab assistant. What that means.

Two Nobel Prizes in a single year went to AI work. A 2026 Nature paper shows an AI system compressing an 872-hour research cycle into under two hours. Scientists using AI publish three times as many papers, yet the same study records a 22% drop in collaboration. All of it is true at once.

In October 2024, the Nobel Committee awarded the Physics prize to Geoffrey Hinton and John Hopfield for their foundational work on neural networks. Within the same week, the Chemistry prize went to Demis Hassabis, John Jumper, and David Baker for AlphaFold and computational protein design. Two disciplines, one year, and both prizes honored AI.

It was the clearest institutional signal yet that the way science gets done had changed. Rather than proving a concept, the awards looked back and acknowledged a transformation that was already underway.

In May 2026, two back-to-back Nature papers showed what came next. Google DeepMind's Co-Scientist and FutureHouse's Robin are multi-agent AI systems that do far more than help with isolated research steps. They generate hypotheses, design experiments, analyze data, refine the research question, and then go around the cycle again. Robin is built specifically for experimental biology. In one demonstration, it identified promising drug candidates for dry age-related macular degeneration, the leading cause of blindness in wealthy countries. It linked a literature-search agent with a biological data-analysis agent and ran an entire discovery cycle that a human research team would need roughly 872 hours to finish. Robin finished it in under two hours.

This is the moment Peter Lee, president of Microsoft Research, had described earlier in 2026: "A world where every research scientist has AI lab assistants that suggest and run parts of experiments." That world isn't on its way. It has already arrived, unevenly and incompletely, but unmistakably.

From tool to research partner: what really shifted

AlphaFold shows how complete the shift has already become in one field. Before it, predicting a protein's three-dimensional structure from its amino acid sequence was a problem scientists had struggled with for fifty years. Determining structures experimentally was expensive and slow, and access clustered at well-funded institutions. The top 10% of universities by prestige published 55% of all articles in leading structural biology journals and captured half the research grants.

In 2021, AlphaFold cracked the folding problem with a median error below one angstrom, which is atomic accuracy. By 2026, 3 million researchers in more than 190 countries use it, including over a million in low- and middle-income countries. More than 30% of AlphaFold-related research centers on disease. John Jumper, the senior DeepMind scientist who led the project, told Fortune in late 2025: "It is just a part of training to be a molecular biologist."

A tool specialized enough to win a Nobel Prize has become standard graduate coursework. That's how fast this transition is moving.

Google DeepMind's GNoME brought the same approach to materials science. It discovered 2.2 million new crystal structures, among them 52,000 novel lithium-ion conductors. External researchers have already synthesized 736 of those predictions in the lab, more new inorganic materials made from computational prediction than the entire earlier literature had produced. These improvements aren't hypothetical. The compounds exist.

What AI is doing inside labs right now

Actual research practice in 2026 is more textured than the headline systems suggest. Most scientists have folded AI into their workflows at least partly, mainly for writing help, literature search, and code generation. The transformative uses, the ones yielding truly novel results, are more concentrated but growing.

At Stanford HAI's AI+Science conference in May 2026, James Zou described a demonstration from his lab. His team asked a set of AI agents to design protein binders for new COVID variants. Within days, the agents had produced new antibody designs, which Zou's lab then synthesized and tested in a wet lab. The AI handled the combinatorial design work that would once have demanded a great deal of human time and specialized expertise. The wet-lab validation, which needs physical hands and domain judgment, stayed with people.

That split holds across the documented 2026 cases. AI systems are strongest at the combinatorial, pattern-recognition, and literature-synthesis tasks that eat the most research time while needing the least human judgment. They're weaker, and humans remain essential, at running experiments, interpreting anomalous results in context, and deciding which questions deserve asking in the first place.

Robin's architecture reflects this. It uses three specialized sub-agents: Crow and Falcon for literature retrieval and scientific reasoning, and Finch for analyzing biological datasets such as RNA sequencing and flow cytometry. The system advances from hypothesis to experimental proposal to data interpretation, but human scientists must confirm the route at each stage. Omar Abudayyeh, a Harvard Medical School biochemist whose lab was acknowledged in DeepMind's Co-Scientist paper, stated where this is going: "Soon, these systems will seamlessly interface with automated wet labs, allowing them to independently propose hypotheses, direct robotic platforms to validate them experimentally, and continuously refine their models based on real-time results."

"AI will join in the process of discovery, creating a world where every research scientist has AI lab assistants that suggest and run parts of experiments."
Peter Lee, President, Microsoft Research, 2026

The productivity data and its uncomfortable other half

The productivity figures from AI adoption in research are striking. A materials science study comparing AI-assisted scientists with their non-AI peers found that the AI-assisted teams discovered 44% more compounds, and that those compounds had measurably better properties. Downstream, that translated to a 39% rise in patent filings and a 17% increase in product prototypes built with the new materials.

A 2026 cross-disciplinary study by Hao et al. found that scientists doing AI-augmented research publish 3.02 times more papers, collect 4.84 times more citations, and reach project leadership positions 1.37 years earlier than peers who don't use AI.

Those are career-defining advantages. If a graduate student in 2026 has access to AI research tools and a classmate doesn't, the difference in publications and citations five years on would be structural, not marginal.

The same Hao study contains the numbers that never reach the press releases. AI adoption was linked to a 4.63% narrowing in the breadth of scientific topics studied and a 22% decline in collaboration and engagement among scientists. The first finding suggests that AI amplifies existing research directions instead of opening genuinely new lines of inquiry. The second suggests that a powerful AI collaborator on your laptop may weaken the incentive to look for human collaborators across institutions and disciplines.

Together, the two findings describe science speeding up along familiar paths while narrowing in scope: high output, concentrated exploration. Discovery is getting faster, and its shape is changing too.

Who actually has an AI lab assistant

Peter Lee's phrase, "every research scientist," is right about the direction but loose about the pace. In principle the tools exist for every researcher. In practice, access is uneven in ways that follow existing inequalities.

AlphaFold is the most democratized example. Its open-access release was deliberate, and its 1 million-plus users in low- and middle-income countries show real distribution beyond wealthy institutions. But AlphaFold takes protein sequences, a well-defined input that needs no specialized infrastructure to supply. Systems like Robin demand that researchers bring their own biological datasets, have the computing infrastructure to run the agents, and hold the domain expertise to judge whether the system's hypotheses are meaningful or garbage.

The World Bank's World Development Report 2026 stated the structural worry directly: AI could widen the gap between high- and lower-income countries "because of its onerous requirements for computing power, data, and skills." The UNDP made the same point in its December 2025 assessment, warning of "a new era of divergence" as countries start the AI transition from highly uneven positions.

Inside wealthy institutions, access is also uneven, though differently. The researchers who gain most from AI lab assistants already publish well, already have deep domain knowledge, and already have collaborators who can validate AI-generated hypotheses. The Hao study's finding that AI users become project leaders 1.37 years sooner reflects genuine productivity gains in part, and in part the fact that early adopters were concentrated among researchers with the resources and networks to adopt early. The productivity multiplier may be amplifying existing advantages as much as it creates new access.

There is a real counterargument. Before AlphaFold, a researcher at a well-funded structural biology lab had X-ray crystallography equipment, cryo-EM facilities, and teams of specialists, while a researcher at an underfunded institution had none of that. AlphaFold removed that specific hardware barrier for protein structure prediction. The question is whether every later AI research tool extends the same equalizing logic, or whether the infrastructure demands of more complex agentic systems hand the advantage back to well-resourced institutions.

What this means for early-career researchers

Graduate students and postdocs starting out in 2026 face choices their predecessors never had to make.

The first concerns which skills to build. A student who learned structural biology before AlphaFold had to understand crystallography, grasp the experimental techniques that produced AlphaFold's training data, and develop first-principles intuition about protein structure. A student learning the field today can take correct structure predictions from AlphaFold as a starting point, possibly without ever developing a deep experimental understanding of why a structure has the properties it does. Does that understanding matter for their eventual research, or is competent fluency with the AI tools the more relevant skill?

Jonathan Gootenberg, who runs a Harvard lab jointly with Abudayyeh, framed it clearly in the context of Co-Scientist: "The real test of any AI-driven discovery system will be the insight it produces." That standard matters. An AI system that churns out high-throughput results of low scientific value doesn't speed up science. It generates noise that researchers must filter. Judging whether an AI's hypothesis is interesting, whether its experimental design truly tests what it claims to test, and whether its data analysis has found a real signal still takes human judgment. Exercising that judgment takes domain knowledge, and that knowledge has to come from somewhere.

"While we are optimistic about the field, the product of these tools will be the final judge."
Jonathan Gootenberg, Harvard Medical School, on AI-driven discovery systems, 2026
The second choice concerns which research questions to pursue. The topic narrowing documented in the Hao study creates a potential opening for researchers willing to work in truly unexplored areas, where AI tools have less prior literature to draw on. AI systems excel at generating hypotheses within the space of known relationships. They're weaker at recognizing that a question nobody has asked is the more important one. That ability remains distinctly human, and it may become a stronger differentiator as AI takes over the known-space work.

What to take from this, whether you're a researcher or a student

Learn the tools, but keep track of where your judgment comes from. Using AlphaFold, running Co-Scientist, and building workflows around Robin's architecture are all real productivity investments. The danger is outsourcing the intuition that builds when you struggle through the slow version. Make a habit of understanding why the AI's output is correct or interesting, not merely that it produced output.
Treat the topic-narrowing finding as a prompt, not a warning. If AI tools are reinforcing existing research directions, the questions nobody has asked yet become more valuable, not less. Areas with no AI training corpus, where hypotheses can't be generated from prior literature, are where truly novel work is likelier to live.
Use the collaboration data deliberately. The 22% decline in collaboration is an aggregate finding. It doesn't mean every AI-using researcher becomes more isolated, only that the average AI user reached out to human collaborators less. You can counter that by letting AI handle literature review and routine hypothesis work, then spending the freed-up time on cross-disciplinary partnerships with people. That way you capture the productivity gain and the diversity of perspective both.
Know which tools need infrastructure you don't have. AlphaFold runs on a laptop. Robin needs biological datasets and computing resources that vary widely by institution. Understanding each tool's real access requirements keeps you from adopting tools on paper while lacking the infrastructure to use them well.
Watch the interface between agentic systems and wet labs. The most significant near-term development in AI research is the link between hypothesis-generating systems and automated physical laboratories. Once Robin can direct a robotic platform to run the experiment it proposes, the human role shifts further toward framing the right question and judging whether the answer means anything. Researchers who have thought carefully about that role will be better placed when the interface reaches their institution.

What the Nobel Prizes said without saying it

By giving two prizes to AI work in a single year, the Nobel Committee was recognizing something specific: some of the decade's most consequential scientific insights came from computational methods, not bench experiments. AlphaFold didn't win because of one clever paper. It won because 3 million researchers found it truly useful, because it changed what was possible in structural biology, and because its discoveries trace back to real clinical and therapeutic applications.

The question raised by Robin's Nature paper, by Co-Scientist's results, and by GNoME's 2.2 million crystal structures isn't whether AI will play a significant role in science. Stockholm settled that in 2024.

What remains open is who gets the tools, which skills stay distinctively valuable once the tools exist, and whether the acceleration along familiar research paths costs us the truly unexpected discoveries that defined the most important science of earlier generations. Both the speed and the shape of discovery are changing. Learning to navigate that change is now as much a part of scientific training as learning to pipette.

Enjoyed this read? Be sure to follow me for more stories that make people feel things. You can also connect with me on LinkedIn or Telegram @kawsarlog for more updates on my work.

I do freelance scraping projects, so if you need some data collected feel free to contact me on LinkedIn or email at hi@kawsarlog.com

Top comments (0)